Slug:opella-mexico-enterogermina-investment Opella has invested $70 million in a new Enterogermina [...]

DFE Pharma has launched a new continuous manufacturing platform in [...]

As global trade policies shift and compliance pressures mount, pharma [...]

Purpose, precision and progress: Jenny's advice on building a career that delivers. With more than 30 years of cross-functional experience spanning manufacturing, R&D, supply chain and commercial strategy, Jenny Gattari brings a rare depth of insight to her role as Global Business Development Lead at Pfizer CentreOne.

Lonza has unveiled a new model-based development platform, Design2Optimize, which [...]